Skip to main content

Cardiovascular Gene Therapy

  • Chapter
Book cover Principles of Molecular Medicine

Abstract

Recombinant DNA technology has provided invaluable tools for understanding the molecular basis of cardiovascular diseases. Elucidation of the underlying molecular genetic mechanisms of cardiovascular disease has led to the emergence of gene therapy as an appealing therapeutic approach. Gene therapy involves the introduction and expression of recombinant DNA in order to ameliorate or cure a disease condition. Despite the extensive publicity devoted to gene therapy, it must be emphasized that this field is still very much in its infancy, and fundamental questions regarding efficacy, safety, and clinical benefit remain unanswered. Initial clinical trials in cardiovascular gene therapy are at an early stage, and the place of gene therapy within the armamentarium of cardiovascular therapeutics remains uncertain. This chapter is devoted principally to a review of the theoretical basis for cardiovascular gene therapy, as established by in vitro and preclinical animal experiments. In addition, the two currently approved human cardiovascular gene-therapy trials (familial hypercholesterolemia [FH; MIM # 14389] and peripheral arterial disease) are discussed, and the likely future directions of the field are summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected References

  • Chang MW, Barr E, Seltzer J, et al. Cytostatic gene therapy for vascular proliferative disorders using a constitutively active form of RB. Science 1995; 267: 518–522.

    Article  PubMed  CAS  Google Scholar 

  • Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WR, Clowes AW. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 1994; 93: 644–651.

    Article  PubMed  CAS  Google Scholar 

  • Dichek DA, Anderson J, Kelly AB, Hanson SR, Harker LA. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 1996; 93: 301–309.

    Article  PubMed  CAS  Google Scholar 

  • Dzau VJ, Mann MJ, Morishita R, Kaneda Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc Natl Acad Sci USA 1996; 93: 11, 421–11, 425.

    Google Scholar 

  • Flugelman MY, Jaklitsch MT, Newman KD, et al. Low level in vivo gene transfer into the arterial wall through a perforated balloon-catheter. Circulation 1992; 85: 1110–1117.

    Article  PubMed  CAS  Google Scholar 

  • Grossman M, Rader DJ, Muller DWM, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1995; 1: 1148–1154.

    Article  PubMed  CAS  Google Scholar 

  • Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812–2816.

    Article  PubMed  CAS  Google Scholar 

  • Isner JM, Walsh K, Symes J, et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995; 91: 2687–2692.

    Article  PubMed  CAS  Google Scholar 

  • Kopfler WP, Willard M, Betz T, Willard JE, Gerard JE, Meidell RS. Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 1994; 90: 1319–1327.

    Article  PubMed  CAS  Google Scholar 

  • Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 1129–1144.

    Google Scholar 

  • Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 1993; 73: 797–807.

    Article  PubMed  CAS  Google Scholar 

  • Nabel EG, Plautz G, Nabel GJ. Site-specific gene-expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285–1288.

    Article  PubMed  CAS  Google Scholar 

  • Nabel E. Gene therapy for cardiovascular disease. Circulation 1995; 91: 541–547.

    Article  PubMed  CAS  Google Scholar 

  • Newman KD, Dunn PF, Owens JW, et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955–2965.

    Article  PubMed  CAS  Google Scholar 

  • O’Brien ER, Schwartz SM. Update on the biology and clinical study of restenosis. Trends Cardiovasc Med 1994; 4: 169–178.

    Article  PubMed  Google Scholar 

  • Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265: 781–784.

    Article  PubMed  CAS  Google Scholar 

  • Rade JJ, Schulick AH, Virmani R, Dichek DA. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med 1996; 2: 293–298.

    Article  PubMed  CAS  Google Scholar 

  • Schulick AH, Newman KD, Virmani R, Dichek DA. In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity. Circulation 1995; 91: 2407–2414.

    Google Scholar 

  • Spady DK, Cuthbert JA, Willard MN, Meidell RS. Adenovirus-mediated transfer of a gene encoding cholesterol 7a-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 1995; 96: 700–709.

    Article  PubMed  CAS  Google Scholar 

  • von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137–1141.

    Article  PubMed  Google Scholar 

  • Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest 1995; 95: 1710–1716.

    Article  PubMed  CAS  Google Scholar 

  • Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004–2115.

    PubMed  CAS  Google Scholar 

  • Zoldhelyi P, McNatt J, Xu X-M, et al. Prevention of arterial thrombosis by adenovirus-mediated gene transfer of cyclooxygenase gene. Circulation 1996; 93: 10–17.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Vassalli, G., Dichek, D.A. (1998). Cardiovascular Gene Therapy. In: Jameson, J.L. (eds) Principles of Molecular Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-726-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-726-0_18

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6272-3

  • Online ISBN: 978-1-59259-726-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics